EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of in vitro reporter gene induction assays for use in a rapid prescreen for compound selection to test specificity in the Tg.AC mouse short-term carcinogenicity assay



Evaluation of in vitro reporter gene induction assays for use in a rapid prescreen for compound selection to test specificity in the Tg.AC mouse short-term carcinogenicity assay



Toxicological Sciences 57(1): 43-53



Under ICH guidelines, short-term carcinogenicity assays such as the Tg.AC assay are allowed alternatives for one species in the 2-year rodent bioassay. The Tg.AC transgenic mouse, which carries the v-Ha-ras oncogene under control of the zeta-globin promoter, develops skin papillomas in response to dermal application of carcinogens and tumor promoters. The appropriate specificity of the Tg.AC model for testing pharmaceuticals has not been systematically evaluated. The selection of candidate test compounds among noncarcinogenic pharmaceuticals would be aided by a high-throughput in vitro prescreen correlative of activity in the in vivo Tg.AC assay. Here we describe the development of a prescreen based on correct response to 24 compounds tested previously in Tg.AC mice. The in vitro prescreens, chosen to reflect molecular pathways possibly involved in Tg.AC papilloma formation, consisted of a zeta-globin promoter-luciferase construct stably expressed in K562 cells (Zeta-Luc) and three of the stress-response element-chloramphenicol acetyltransferase (CAT) fusion constructs stably expressed in HepG2 cells that are part of the CAT-Tox (L)iver assay. The stress response elements chosen were the c-fos promoter, the gadd153 promoter, and p53 response element repeats. Of the four assays, the gadd153-CAT assay showed the strongest concordance with activity in the Tg.AC assay, correctly classifying 78% of Tg.AC positive and 83% of Tg.AC negative compounds. The correlation was further improved by adding the Zeta-Luc assay as a second-stage screen. These cell-based assays will be used in a novel approach to selecting candidate compounds that challenge the specificity of the Tg.AC assay toward pharmaceuticals.

(PDF emailed within 0-6 h: $19.90)

Accession: 010616343

Download citation: RISBibTeXText

PMID: 10966510

DOI: 10.1093/toxsci/57.1.43



Related references

Mutagenicity test system based on, a reporter gene assay for short-term detection of mutagens (MutaGen assay). Mutation Research 535(1): 55-72, 2003

Comparison of in Vivo and in Vitro Reporter Gene Assays for Short-Term Screening of Estrogenic Activity. Environmental Science and Technology 36(20): 10-15, 2002

Evaluation of an in vivo in vitro short term carcinogenicity test. Experientia (Basel) 44(ABSTR): A53, 1988

Short-term assays to predict carcinogenicity. Statistical analysis of data from in-vitro assays of mutagenesis. Iarc Scientific Publications: 457-481, 1986

Short-term assays to predict carcinogenicity. In-vitro assays that may be predictive of tumour-promoting agents. Iarc Scientific Publications: 287-302, 1986

Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro. Toxicological Sciences 74(2): 260-270, 2003

Short-term assays to predict carcinogenicity. The host-mediated assay. Iarc Scientific Publications: 163-165, 1986

Short-term assays to predict carcinogenicity. Short-term assays for the analysis of body fluids and excreta. Iarc Scientific Publications: 409-438, 1986

Evaluation of Estrogenic Activity of Wastewater: Comparison Among In Vitro ERĪ± Reporter Gene Assay, In Vivo Vitellogenin Induction, and Chemical Analysis. Environmental Science & Technology 49(10): 6319-6326, 2016

Short- and intermediate-term carcinogenicity testing--a review. Part 1: the prototypes mouse skin tumour assay and rat liver focus assay. Food and Chemical Toxicology 36(11): 979-995, 1998

An initiator transfer rna acceptance assay as a short term test for carcinogenicity. Uicc (union Internationale Contre Le Cancer, International Union Against Cancer)international Cancer Congress, Budapest, Hungary, Aug. 21-27,: Basel, Switzerland; New York, N.y., Usa; Akademiai Kiado: Budapest, Hungary. Paper. 306, 1986

The challenge of testing chemicals for potential carcinogenicity using multiple short-term assays: an analysis of a proposed test battery for hair dyes. Mutation Research 633(1): 55-66, 2007

Short-term assays to predict carcinogenicity. Short-term assays using bacteria. Iarc Scientific Publications: 143-161, 1986

Micronucleus test as a short-term assay for detecting the potential carcinogenicity of different groups of chemical compounds. Eksperimental'naia Onkologiia 9(2): 8-14, 1987

Development of an in vitro reporter gene assay to assess xenobiotic induction of the human CYP3A4 gene. European Journal of Drug Metabolism and Pharmacokinetics 22(4): 311-313, 1998